Skip to main content
SpringerLink
Log in

Sclerodermiform porphyria cutanea tarda after torasemide

  • Correspondence
  • Published:
European Journal of Dermatology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Doyle J, Friedman S. Porphyria and Scleroderma: a clinical and laboratory review of 12 patients. Australas J Dermatol 1983; 24: 109. 14.

    Article  PubMed  CAS  Google Scholar 

  2. Grossman M, Poh-Fitzpatrick M. Porphyria cutanea tarda. Diagnosis and management. Med Clin North Am 1980; 64: 807–27.

    PubMed  CAS  Google Scholar 

  3. Khajat R, Dupuy A, Pansé I, Bagot M, Cordoliani F. Sclerodermatous changes in porphyria cutanea tarda: Six cases. Ann Dermatol Venereol 2013; 140: 589–97.

    Article  Google Scholar 

  4. Mino Y, Iwanaga A, Ikehara Y, Takamura N, Utani A. Pseudoxanthoma elasticum-like skin lesions with congenital erythropoetic porphyria. Eur J Dermatol 2014; 24: 401–2.

    Google Scholar 

  5. Varigos G, Schiltz J, Bickers D. Uroporphyrin I stimulation of collagen biosynthesis in human skin fibroblasts: a unique dark effect of porphyrin. J Clin Invest 1982; 69: 129–35.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Lanconi G, Ravinal R, Costa R, Roselino A. Mast cells and transforming growth factor-expression: a possible relationship in the development of porphyria cutanea tarda skin lesions. Int J Dermatol 2008; 47: 575–81.

    Article  PubMed  Google Scholar 

  7. Liakou A, Zouboulis C. Drug-induced photodermatitis in elderly nursing home residents. J Dtsch Dermatol Ges 2011; 9: 631–2.

    PubMed  Google Scholar 

  8. Brater D. Pharmacokinetics and pharmacodynamics of torasemide in health and disease. J Cardiovasc Pharmacol 1993; 22: 24–31.

    Article  Google Scholar 

  9. Knauf H, Mutschler E. Clinical pharmacokinetics and pharmacodynamics of torasemide. Clin Pharmacokinet 1998; 34: 1–24.

    Article  PubMed  CAS  Google Scholar 

  10. Friedman S, Doyle J. Sclerodermoid changes of porphyria cutanea tarda: possible relationship to urinary uroporphyrin levels. J Am Acad Dermatol 1985; 13: 70–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Medical University Graz, Auenbruggerplatz 8, 8036, Graz, Austria

    Bettina Kranzelbinder, Michaela Wiednig, Laila El-Shabrawi-Caelen, Werner Aberer & Elisabeth Aberer

Authors
  1. Bettina Kranzelbinder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michaela Wiednig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laila El-Shabrawi-Caelen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Werner Aberer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elisabeth Aberer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bettina Kranzelbinder.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kranzelbinder, B., Wiednig, M., El-Shabrawi-Caelen, L. et al. Sclerodermiform porphyria cutanea tarda after torasemide. Eur J Dermatol 25, 484–485 (2015). https://doi.org/10.1684/ejd.2015.2556

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2015.2556

Keywords

Search

Navigation